Core Viewpoint - The article highlights significant developments in the scientific instrument industry, including policy changes, product innovations, and collaborations aimed at enhancing research capabilities and industry standards [2][4][11]. Policy and Industry Standards - Sichuan Province has implemented a new policy for sharing major scientific research infrastructure and large scientific instruments, mandating that instruments valued at 500,000 yuan or more be included in a provincial sharing platform, effective July 18, 2025 [2]. Manufacturer Dynamics and New Product Releases - Suzhou Bozhong Instrument Technology Co., Ltd. launched China's first commercial 200 kV field emission transmission electron microscope (TEM) with a point resolution of 0.25 nanometers, targeting semiconductor wafer defect detection and lithium battery analysis [4]. - Shanghai Yidian Scientific Instruments participated in CPHI China 2025, showcasing GMP-compliant titrators, moisture analyzers, and spectroscopic chromatography instruments, along with providing 3Q certification services [5][6]. - Zhuomao Technology released the AXI9000, a high-speed CT X-ray automatic detection device, addressing the limitations of traditional 2D detection for 3D defect inspection in the electronics manufacturing sector [7]. - Leibertai Technology reported that its mass spectrometer series has competitive core performance indicators, with plans to accelerate import substitution through mergers and acquisitions [8]. - Huizhou Huagao Instruments introduced the DM&S SMS-1000 flash point tester, utilizing multi-point non-destructive testing technology, achieving over a 50% reduction in error rates compared to traditional methods [9]. Laboratory and Research Collaborations - Anhui Yi Technology and Hefei Comprehensive National Science Center signed an agreement to establish a joint laboratory for the development of key vacuum measurement equipment for nuclear fusion [11]. - The Hunan Provincial Drug Inspection Institute successfully passed the CNAS address change review, enhancing its testing capabilities for pharmaceuticals and medical devices [12]. - The Chenzhou Laboratory aims to optimize research models through industry-academia collaboration, focusing on key technologies to meet enterprise needs [13]. - A partnership between Heilongjiang Province's environmental monitoring center and Heilongjiang University aims to cultivate 200 interdisciplinary technical talents over three years to support ecological monitoring [14]. Patents and Technological Breakthroughs - Hunan Shuikoushan Nonferrous Metals Group obtained a patent for a method to determine silver, platinum, and palladium in high-silver gray powder, achieving a detection error of less than 0.3% and reducing chemical reagent consumption by 90% [17]. - Jiangsu Luben Instruments applied for a patent for an ion source structure and processing equipment, enhancing production capacity while reducing equipment size and process costs [17]. - Various companies, including Suzhou Fushida and Tianjin Jianzhijian Testing, have obtained patents for innovative testing devices, improving measurement accuracy and efficiency in their respective fields [19][20]. Standards and Testing Technologies - The first domestic standard for fluoroquinolone drug sensitivity testing was published, providing a technical basis for treating multi-drug resistant bacterial infections [24]. - Ningxia has approved seven group standards aimed at improving detection efficiency and accuracy in food testing and microbiological technology [25]. - An international standard for testing the microwave reheating suitability of ceramic tableware was released, ensuring safety in food packaging applications [26]. Industry Events and Activities - The "Rong Craftsman Cup" skill competition for the seasoning industry was launched to accelerate technological upgrades and talent cultivation in Sichuan Province [28]. - DXOMARK released a new benchmark for smartphone imaging tests, enhancing evaluation standards for HDR, zoom, and video shooting [29]. - The Laser World of Photonics 2025 event in Munich showcased advanced optical instruments and solutions, attracting professionals from various countries [30]. - The China International Optical Instruments Exhibition is set to take place, featuring a high-profile forum on optical technology and applications [31].

Core Viewpoint - The report outlines the equity changes of LabTech Holdings, Inc. and its affiliates in Beijing LabTech Instrument Co., Ltd., indicating a reduction in their shareholding percentage due to passive dilution and a share transfer [7][10][21]. Group 1: Equity Change Details - The equity change is attributed to passive dilution from the increase in total share capital due to the vesting of restricted stock and a share transfer by Beijing LabTech Management Consulting Co., Ltd. [7][8] - The shareholding percentage of the information disclosing party decreased from 60.89% to 57.48% following the transfer of 2,023,573 shares, which represents 3.00% of the total share capital [10][22]. - The total share capital increased by 198,600 shares on June 16, 2022, 37,800 shares on December 16, 2022, and 216,060 shares on November 13, 2024, leading to a passive dilution of the shareholding percentage [9][27]. Group 2: Share Transfer Process - The share transfer was conducted through a price inquiry, with the final transfer price set at 29.19 yuan per share [20][30]. - A total of 411 institutional investors were invited to participate in the inquiry, with 20 valid bids received from 17 participating institutions [29][30]. - The transfer does not result in a change of control for the company, as the controlling shareholder remains the same [21][30].

Core Viewpoint - The report outlines a significant change in the shareholding structure of Beijing LabTech Instrument Co., Ltd, indicating a passive dilution of shares and a reduction in the overall ownership percentage of the information disclosing parties from 60.89% to 57.48% due to stock incentive plans and share transfers [1][5][6]. Group 1: Shareholding Changes - The shareholding percentage of the information disclosing parties decreased from 60.89% to 57.48% as a result of passive dilution and a share transfer by Beijing LabTech Management Consulting Co., Ltd [5][6]. - The total number of shares held by the information disclosing parties before the transfer was 40,795,000, which represented 60.89% of the total issued shares. After the transfer, the number of shares decreased to 38,771,427, representing 57.48% of the total issued shares [8][14]. Group 2: Share Transfer Details - The share transfer involved a total of 2,023,573 shares, which were sold through a price inquiry transfer method [6][7]. - The share transfer was executed on June 13, 2025, and was part of a broader strategy to meet the financial needs of the transferring party [5][6]. Group 3: Future Plans - As of the report date, there are no definitive plans from the information disclosing parties to increase or decrease their shareholding in the next 12 months, although such actions are not ruled out [5][14]. - The information disclosing parties have committed to adhering to relevant laws and regulations regarding any future shareholding changes [5][14].

Core Viewpoint - The report details the results of a share transfer by Beijing Laibotai Technology Instrument Co., Ltd., indicating a decrease in the shareholding percentage of its controlling shareholder, Beijing Laibotai Management Consulting Co., Ltd., from 60.89% to 57.48% following the transfer of 2,023,573 shares at a price of 29.19 yuan per share [1][2][5]. Summary by Sections 1. Transfer Details - The share transfer price was set at 29.19 yuan per share, with a total of 2,023,573 shares being transferred [1]. - The controlling shareholder, Beijing Laibotai Management Consulting Co., Ltd., did not participate in the transfer through its indirect holdings [1]. - The transfer is classified as a passive dilution and will not result in a change of control for the company [1][5]. 2. Shareholder Information - As of June 9, 2025, the shareholding structure shows that the transferor, Beijing Laibotai Management Consulting Co., Ltd., held 24,177,000 shares, representing 35.84% of the total shares before the transfer [2]. - After the transfer, the shareholding percentage of the management consulting firm and its concerted actors decreased to 57.48% [2][3]. 3. Transfer Process - The transfer was conducted through an inquiry process, with a price determined based on the average trading price of the stock over the previous 20 trading days [5]. - A total of 411 institutional investors received the subscription invitation, with 20 valid bids received from 17 participating institutions [5]. - The final allocation of shares was made to five investors, confirming the transfer price of 29.19 yuan per share [5]. 4. Regulatory Compliance - The transfer process adhered to relevant laws and regulations, ensuring fairness and compliance with market standards [7].

上市公司名称： 北京莱伯泰科仪器股份有限公司 股票上市地点： 上海证券交易所 股票简称： 莱伯泰科 股票代码： 688056.SH 信息披露义务人1： 北京莱伯泰科管理咨询有限公司 住所及通讯地址： 北京市朝阳区呼家楼（京广中心）11层商务单元1132 信息披露义务人2： LabTech Holdings, Inc 住所及通讯地址： 美国特拉华州纽卡斯尔县威明顿市橘子街1209号 信息披露义务人3： 北京兢业诚成咨询服务有限公司 住所及通讯地址： 北京市顺义区空港工业区B区安庆大街6号 股份变动性质： 股份减少（被动稀释、询价转让） 北京莱伯泰科仪器股份有限公司 简式权益变动报告书 签署日期：2025年6月13日 信息披露义务人声明 一、信息披露义务人根据《中华人民共和国证券法》（以下简称"《证券 法》"）《上市公司收购管理办法》（以下简称"《收购办法》"）《公开发行证 券公司信息披露内容与格式准则第 15 号——权益变动报告书》（以下简称 "《准则 15 号》"）等相关的法律、法规及规范性文件编写本报告书。 二、信息披露义务人签署本报告书已获得必要的授权和批准，其履行亦不 违反信息披露义务人内部规则中的任何 ...

证券代码：688056 证券简称：莱伯泰科 公告编号：2025-025 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示: 本次询价转让的价格为29.19元/股，转让的股票数量为2,023,573股。 北京莱伯泰科仪器股份有限公司（以下简称"莱伯泰科"或"公司"） 控股股东（公司实际控制人控制的一致行动人）北京莱伯泰科管理咨询有限公司 （以下简称"管理咨询"或"转让方"）参与本次询价转让，公司实际控制人承诺 通过管理咨询间接持有的股份不参与本次询价转让；部分董事、高级管理人员（即 公司实际控制人、董事长兼总经理胡克）通过管理咨询间接持有股份。 本次权益变动为被动稀释、询价转让，本次转让不会导致公司控股股东、 实际控制人发生变化。 北京莱伯泰科仪器股份有限公司 股东询价转让结果报告书暨持股 5%以上股东权益变动 跨越 5%整数倍的提示性公告 北京莱伯泰科管理咨询有限公司保证向北京莱伯泰科仪器股份有限公司提供的 信息内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、准确性 和完整性依法承担法律责任。 本次权益变动后，管理咨询及其一致行动人持有公司股份比例由60.89% ...

中信证券股份有限公司 关于北京莱伯泰科仪器股份有限公司 股东向特定机构投资者询价转让股份的核查报告 上海证券交易所： 中信证券股份有限公司（以下简称"中信证券"或"组织券商"）受委托担 任北京莱伯泰科管理咨询有限公司（以下简称"转让方"）以向特定机构投资者 询价转让（以下简称"询价转让"）方式减持所持有的北京莱伯泰科仪器股份有 限公司（以下简称"公司"或"莱伯泰科"）首次公开发行前已发行股份的组织 券商。 经核查，中信证券就本次询价转让的股东、受让方是否符合《上海证券交易 所科创板上市公司自律监管指引第 4 号——询价转让和配售（2025 年 3 月修订）》 （以下简称"《询价转让和配售指引》"）要求，本次询价转让的询价、转让过 程与结果是否公平、公正，是否符合《询价转让和配售指引》的规定作出如下报 一、本次询价转让概况 （一）本次询价转让转让方 截至 2025 年 6 月 9 日转让方所持公司首发前股份的数量及占公司总股本比 例情况如下： | 序号 | 股东名称 | 截至 2025 年 6 月 9 日 | 持股比例 | | --- | --- | --- | --- | | | | 收盘持股数量（股） | ...

本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 根据 2025 年 6 月 10 日询价申购情况，本次询价转让初步确定的转让价 格为 29.19 元/股。 一、本次询价转让初步定价 （一）经向机构投资者询价后，北京莱伯泰科仪器股份有限公司（以下简称 "公司"）股东询价转让（以下简称"本次询价转让"）初步确定的转让价格为 29.19 元/股。 （二）参与本次询价转让报价的机构投资者家数为 17 家，涵盖了基金管理 公司、合格境外机构投资者、私募基金管理人、证券公司等专业机构投资者。参 与本次询价转让报价的机构投资者合计有效认购股份数量为 7,785,000 股，对应 的有效认购倍数为 3.85 倍。 （三）本次询价转让拟转让股份已获全额认购，初步确定受让方为 5 家机构 投资者，拟受让股份总数为 2,023,573 股。 北京莱伯泰科管理咨询有限公司保证向北京莱伯泰科仪器股份有限公司提 供的信息内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、 准确性和完整性依法承担法律责任。 北京莱伯泰科仪器股份有限公司 股东询价转让定价情况提示性公告 证券代码：688056 ...

Group 1 - Vanke A announced the sale of 22 million A-share treasury stocks for a total of 146 million yuan, representing 0.18% of the company's total share capital, aimed at supplementing liquidity without impacting current profits [1] - Tencent Music plans to acquire 100% of Himalaya for a total consideration of $1.26 billion, which includes cash and shares, to expand its audio content ecosystem [1] - Dongfang Electric Heat signed a strategic cooperation agreement with Xiaomi's subsidiary to develop robotic electronic skin, focusing on flexible fabric pressure sensing applications [3] Group 2 - Chengdu Huamei launched a 4-channel, 12-bit, 16G high-precision RF direct sampling ADC chip, marking a significant breakthrough in high-speed data conversion technology [4] - Jinshi Technology clarified that it has not engaged in any business related to stablecoins, despite recent market interest, and noted a significant stock price increase of 76.51% over six trading days [5] - Xiantan Co. reported a 14.22% year-on-year increase in chicken product sales revenue for May, amounting to 469 million yuan [7]

? 根据 2025 年 6 月 10 日询价申购情况，本次询价转让初步确定的转让价 格为 29.19 元/股。 证券代码：688056 证券简称：莱伯泰科 公告编号：2025-024 北京莱伯泰科仪器股份有限公司 北京莱伯泰科管理咨询有限公司保证向北京莱伯泰科仪器股份有限公司提 供的信息内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其真实性、 准确性和完整性依法承担法律责任。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： （三）本次询价转让拟转让股份已获全额认购，初步确定受让方为 5 家机构 投资者，拟受让股份总数为 2,023,573 股。 二、风险提示 （一）本次询价转让受让方及受让股数仅为初步结果，尚存在拟转让股份被 司法冻结、扣划等风险。询价转让的最终结果以中国证券登记结算有限责任公司 上海分公司最终办理结果为准。 （二）本次询价转让不涉及公司控制权变更，不会影响公司治理结构和持续 经营。 特此公告。 一、本次询价转让初步定价 （一）经向机构投资者询价后，北京莱伯泰科仪器股份有限公司（以下简称 "公司"）股东询价转让（以下简称"本次询价转让"）初步确定的转让 ...